Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

qpharma pty ltd - chlortetracycline hydrochloride - oral powder, pre-mix - chlortetracycline hydrochloride antibiotic active 100.0 mg/g - antibiotic & related - birds - ornamental | amazon parrot | caged bird | canary | cockatiel | cockatoo | conure | finch | lovebird | macaw | ornamental - bacteria sensitive to chlortetracycline | enteritis associated with e.coli | mycoplasma spp. | psittacosis/ornithosis

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bec feed solutions pty ltd - chlortetracycline hydrochloride - oral powder, pre-mix - chlortetracycline hydrochloride antibiotic active 10.0 g/kg - nutrition & metabolism - calf | pig - piglet | beef calf | bovine | calf - poddy | calf - preweaning | calf - sucker | dairy calf | neonatal calf | neona - bacteria sensitive to chlortetracycline

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zamira life sciences pty ltd - chlortetracycline hydrochloride - oral powder, pre-mix - chlortetracycline hydrochloride antibiotic active 950.0 g/kg - antibiotic & related

Kanada - angličtina - Health Canada

bio agri mix lp - chlortetracycline hydrochloride; vitamin a; vitamin d3; vitamin e - drug premix - 4.4g; 550000unit; 55000unit; 550unit - chlortetracycline hydrochloride 4.4g; vitamin a 550000unit; vitamin d3 55000unit; vitamin e 550unit - cattle; cattle; cattle; swine (pigs)

Spojené štáty - angličtina - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - demeclocycline hydrochloride (unii: 29o079ntyt) (demeclocycline - unii:5r5w9ici6o) - demeclocycline hydrochloride 150 mg - demeclocycline hydrochloride tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions below: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae; respiratory tract infections caused by mycoplasma pneumoniae ; lymphogranuloma venereum due to chlamydia trachomatis ; psittacosis (ornithosis) due to chlamydia psittaci ; trachoma due to chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence; inclusion conjunctivitis caused by chlamydia trachomatis ; nongonococcal urethritis in adults caused by ureaplasma urealyticum or chlamydia trachomatis ; relapsing fever due to borrelia recurrentis ; chancroid caused by haemophilus ducreyi ; plague due to yersinia pestis ; tularemia due to francisella tularensis ; cholera caused by vibrio cholerae ; campylobacter fetus infections caused by campylobacter fetus ; br

Spojené štáty - angličtina - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes, streptococcus pneumoniae and hemophilus influenzae. note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by strep

Spojené štáty - angličtina - NLM (National Library of Medicine)

stat rx usa llc - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

Spojené štáty - angličtina - NLM (National Library of Medicine)

actavis pharma, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride capsules and other antibacterial drugs, tetracycline hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and haemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused

Spojené štáty - angličtina - NLM (National Library of Medicine)

alvogen inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , stre

Spojené štáty - angličtina - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline calcium (unii: nr4b2sx17s) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 220 g in 1 kg - active drug ingredients: chlortetracycline as chlortetracycline calcium complex equivalent to 100 grams chlortetracycline hydrochloride/lb. ingredients: chlortetracycline, calcium carbonate, roughage products and mineral oil. for use in the manufacture of medicated feeds